BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11137332)

  • 1. Possibilities of sterility therapy in a patient with a premature menopause due to an X-chromosomal anomaly - a case report.
    Nawroth F; Foth D; Stute P; Schmidt T; Römer T
    Maturitas; 2000 Dec; 37(2):129-32. PubMed ID: 11137332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy following ovarian induction in a patient with premature ovarian failure and undetectable serum anti-Müllerian hormone.
    Tsuji I; Ami K; Fujinami N
    J Obstet Gynaecol Res; 2013 May; 39(5):1070-2. PubMed ID: 23379594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial estrogen and progesterone receptors in cycles treated for infertility.
    Bourgain C; Smitz J; Vandesteen N; Klöppel G; Devroey P; van Steirteghem AC
    Prog Histochem Cytochem; 1992; 26(1-4):132-9. PubMed ID: 1484956
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful pregnancy in a woman with ovarian failure associated with mutation in the beta-subunit of luteinizing hormone.
    Takahashi K; Ozaki T; Kanasaki H; Miyazaki K
    Horm Res; 2001; 55(5):258-63. PubMed ID: 11740150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The place of cotreatment with growth hormone and human menopausal gonadotropin (hMG) in ovarian stimulation.
    Homburg R; Ben-Rafael Z
    J Assist Reprod Genet; 1996 May; 13(5):371-3. PubMed ID: 8739050
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause.
    Sullivan SD; Sarrel PM; Nelson LM
    Fertil Steril; 2016 Dec; 106(7):1588-1599. PubMed ID: 27912889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ovarian hyperstimulation with menotropins as treatment for unexplained sterility; effect of reproductive characteristics on the results].
    Kably A; Reyes-Cuervo H; Barrón-Vallejo J
    Ginecol Obstet Mex; 1996 Sep; 64():402-5. PubMed ID: 8964541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Coasting: a response to excessive ovarian stimulation].
    Dechaud H; Anahory T; Aligier N; Arnal F; Humeau C; Hédon B
    Gynecol Obstet Fertil; 2000 Feb; 28(2):115-9. PubMed ID: 10758585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premature ovarian failure.
    Barlow DH
    Baillieres Clin Obstet Gynaecol; 1996 Sep; 10(3):361-84. PubMed ID: 8931900
    [No Abstract]   [Full Text] [Related]  

  • 10. New approaches to ovarian stimulation.
    Diedrich K; Felberbaum R
    Hum Reprod; 1998 Jun; 13 Suppl 3():1-13; discussion 14-7. PubMed ID: 9755411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premature ovarian failure and dehydroepiandrosterone.
    Mamas L; Mamas E
    Fertil Steril; 2009 Feb; 91(2):644-6. PubMed ID: 18321501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pregnancy and hormone replacement therapy in a patient with resistant ovary syndrome].
    Nawroth F; Sudik R
    Zentralbl Gynakol; 1999; 121(5):255-7. PubMed ID: 10408080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Outcome and quality of pregnancies obtained by ovulation inducers in infertile women: apropos of 229 pregnancies in 91 women, of whom 42 were treated for spontaneous abortion and 49 treated for ovarian sterility].
    Henry-Suchet J; Burtin M; Cohen J
    J Gynecol Obstet Biol Reprod (Paris); 1973 Sep; 2(6):653-72. PubMed ID: 4807268
    [No Abstract]   [Full Text] [Related]  

  • 14. Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study.
    Hwang JL; Seow KM; Lin YH; Huang LW; Hsieh BC; Tsai YL; Wu GJ; Huang SC; Chen CY; Chen PH; Tzeng CR
    Hum Reprod; 2004 Sep; 19(9):1993-2000. PubMed ID: 15284212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X chromosome mosaicism in patients with recurrent abortion or premature ovarian failure.
    Wu RC; Kuo PL; Lin SJ; Liu CH; Tzeng CC
    J Formos Med Assoc; 1993 Nov; 92(11):953-6. PubMed ID: 7910065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infertility in women: an update.
    Carson DS; Bucci KK
    J Am Pharm Assoc (Wash); 1998; 38(4):480-6; quiz 487-8. PubMed ID: 9707958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical comparison of ovarian stimulation and luteal support agents in patients undergoing GnRH antagonist IVF cycles.
    Miller CE; Zbella E; Webster BW; Doody KJ; Bush MR; Collins MG
    J Reprod Med; 2013; 58(3-4):153-60. PubMed ID: 23539885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premature ovarian insufficiency: how to improve reproductive outcome?
    Ben-Nagi J; Panay N
    Climacteric; 2014 Jun; 17(3):242-6. PubMed ID: 24341612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of GnRH analogue therapy in IVF in women with unexplained infertility.
    Ashkenazi J; Dicker D; Feldberg D; Goldman GA; Yeshaya A; Goldman JA
    Hum Reprod; 1989 Aug; 4(6):667-9. PubMed ID: 2528570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone.
    Filicori M; Cognigni GE; Pocognoli P; Tabarelli C; Ferlini F; Perri T; Parmegiani L
    Fertil Steril; 2003 Aug; 80(2):390-7. PubMed ID: 12909504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.